>
Peak Pharmaceuticals Inc logo

PKPH - Peak Pharmaceuticals Inc Share Price

$0.124 0.0  0.0%

Last Trade - 27/09/21

Sector
Healthcare
Size
Micro Cap
Market Cap £7.10m
Enterprise Value £7.13m
Revenue £n/a
Position in Universe th / 7181
Bullish
Bearish
Unlock PKPH Revenue
Momentum
Relative Strength (%)
1m +35.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -54.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 June 2018, PeakPharmaceuticals Inc revenues was not reported. Net lossdecreased 21% to $21K. Lower net loss reflects Change infair value of convertible debt decrease from $5K (expense)to $0K, General and administrative decrease of 15% to $18K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PKPH Revenue Unlock PKPH Revenue

Net Income

PKPH Net Income Unlock PKPH Revenue

Normalised EPS

PKPH Normalised EPS Unlock PKPH Revenue

PE Ratio Range

PKPH PE Ratio Range Unlock PKPH Revenue

Dividend Yield Range

PKPH Dividend Yield Range Unlock PKPH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PKPH EPS Forecasts Unlock PKPH Revenue
Profile Summary

Peak Pharmaceuticals, Inc. is a development-stage company. The Company operates as a bio-pharmaceutical and nutraceutical company that focuses on developing, manufacturing, marketing and selling medicinal products based on extracts from hemp. The Company's medicinal products are intended for over-the-counter sale through distribution networks applicable to products classified as supplements and nutraceuticals. By using industrial hemp, an ultra-low tetrahydrocannabinol (THC) content cannabis plant, the Company develops and markets products containing cannabinoids. The Company is exploring the use of domestic hemp oils for use in various types of consumer products. The Company was engaged in the development, sales and marketing of online video stores.

Directors
Last Annual September 30th, 2017
Last Interim June 30th, 2018
Incorporated December 18, 2007
Public Since May 17, 2010
No. of Shareholders: n/a
No. of Employees: 1
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 78,363,567
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
PKPH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PKPH
Upcoming Events for PKPH
Frequently Asked Questions for Peak Pharmaceuticals Inc
What is the Peak Pharmaceuticals Inc share price?

As of 27/09/21, shares in Peak Pharmaceuticals Inc are trading at $0.124, giving the company a market capitalisation of £7.10m. This share price information is delayed by 15 minutes.

How has the Peak Pharmaceuticals Inc share price performed this year?

Shares in Peak Pharmaceuticals Inc are currently trading at $0.124 and the price has moved by 0.786k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Peak Pharmaceuticals Inc price has moved by 0.578k% over the past year.

What are the analyst and broker recommendations for Peak Pharmaceuticals Inc?

Of the analysts with advisory recommendations for Peak Pharmaceuticals Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Peak Pharmaceuticals Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Peak Pharmaceuticals Inc next release its financial results?

Peak Pharmaceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-06-30
What is the Peak Pharmaceuticals Inc dividend yield?

Peak Pharmaceuticals Inc does not currently pay a dividend.

Does Peak Pharmaceuticals Inc pay a dividend?

Peak Pharmaceuticals Inc does not currently pay a dividend.

When does Peak Pharmaceuticals Inc next pay dividends?

Peak Pharmaceuticals Inc does not currently pay a dividend.

How do I buy Peak Pharmaceuticals Inc shares?

To buy shares in Peak Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Peak Pharmaceuticals Inc?

Shares in Peak Pharmaceuticals Inc are currently trading at $0.124, giving the company a market capitalisation of £7.10m.

Where are Peak Pharmaceuticals Inc shares listed? Where are Peak Pharmaceuticals Inc shares listed?

Here are the trading details for Peak Pharmaceuticals Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: PKPH
What kind of share is Peak Pharmaceuticals Inc?

We were not able to load our ranking data for Peak Pharmaceuticals Inc

Is there a Peak Pharmaceuticals Inc share price forecast 2021?

Shares in Peak Pharmaceuticals Inc are currently priced at $0.124. At that level they are trading at 0.916% discount to the analyst consensus target price of 0.00.

How can I tell whether the Peak Pharmaceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Peak Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been -17.13%. At the current price of $0.124, shares in Peak Pharmaceuticals Inc are trading at 6.24% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Peak Pharmaceuticals Inc PE Ratio?

We were not able to find PE ratio data for Peak Pharmaceuticals Inc.

Who are the key directors of Peak Pharmaceuticals Inc?

Peak Pharmaceuticals Inc's management team is headed by:

Neil Reithinger - CEO
Who are the major shareholders of Peak Pharmaceuticals Inc?

Here are the top five shareholders of Peak Pharmaceuticals Inc based on the size of their shareholding:

PanAgora Asset Management Inc. Investment Advisor/Hedge Fund
Percentage owned: % (n/a shares)
Similar to PKPH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.